Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v2.4.1.9
Stock-Based Compensation (Tables)
 9 Months Ended
Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Stock option activity is as follows:
 
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining
 
 
 
Options
 
Exercise Price
 
Contractual Life
 
Outstanding, June 30, 2013
 
 
1,508,334
 
$
4.50
 
 
4.6
 
Granted
 
 
2,835,000
 
$
3.14
 
 
 
 
Outstanding, June 30, 2014
 
 
4,343,334
 
$
3.61
 
 
5.6
 
Granted
 
 
4,532,000
 
$
2.03
 
 
 
 
Forfeited
 
 
(212,916)
 
$
3.57
 
 
 
 
Outstanding, March 31, 2015
 
 
8,662,418
 
$
2.78
 
 
7.4
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at March 31, 2015
 
 
2,065,147
 
$
3.95
 
 
4.1
 
 
Schedule Of Warrants Issued To Agents Activity [Table Text Block]
AntriaBio issued warrants to agents and note holders in conjunction with the closing of its convertible notes payable and equity financings as follows:
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining
 
 
 
Warrants
 
Exercise Price
 
Contractual Life
 
Outstanding, June 30, 2013
 
 
293,092
 
$
2.21
 
 
4.1
 
Warrants issued to note holders
 
 
225,259
 
$
1.89
 
 
 
 
Warrants issued to note holders
 
 
4,039,184
 
$
1.98
 
 
 
 
Warrants issued to related party
 
 
39,117
 
$
7.50
 
 
 
 
Warrants issued in private placement
 
 
6,287,679
 
$
2.34
 
 
 
 
Warrants issued to placement agent
 
 
290,861
 
$
1.56
 
 
 
 
Warrants issued for investor relations
 
 
66,667
 
$
3.34
 
 
 
 
Warrants exercised
 
 
(100,550)
 
$
1.17
 
 
 
 
Warrants forfeited
 
 
(41,570)
 
$
1.17
 
 
 
 
Outstanding, June 30, 2014
 
 
11,099,739
 
$
2.21
 
 
3.6
 
Warrants issued in private placements
 
 
5,276,280
 
$
2.50
 
 
 
 
Warrants issued to placement agent
 
 
1,576,937
 
$
2.50
 
 
 
 
Warrants issued for investor relations
 
 
105,000
 
$
1.65
 
 
 
 
Warrants cancelled
 
 
(59,758)
 
$
2.92
 
 
 
 
Outstanding, March 31, 2015
 
 
17,998,198
 
$
2.31
 
 
3.0
 
Black Scholes Pricing Model  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
AntriaBio has computed the fair value of all options granted during the nine months ended March 31, 2015 using the following assumptions:
 
Expected volatility
 
 
90 - 92
%
Risk free interest rate
 
 
1.31% - 1.88
%
Expected term (years)
 
 
5 - 7
 
Dividend yield
 
 
0
%
Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]
The estimated fair value was derived using the lattice model with the following assumptions:
 
Expected volatility
 
 
93
%
Risk free interest rate
 
 
2.21
%
Warrant term (years)
 
 
7
 
Dividend yield
 
 
0
%
Lattice Model One  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]
The estimated fair value was derived using the lattice model with the following assumptions:
 
Expected volatility
 
 
90% - 91
%
Risk free interest rate
 
 
1.89% - 1.98
%
Warrant term (years)
 
 
7
 
Dividend yield
 
 
0
%
Lattice Model Two  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]
The estimated fair value was derived using the lattice model with the following assumptions:
 
Expected volatility
 
 
90
%
Risk free interest rate
 
 
1.71
%
Warrant term (years)
 
 
7
 
Dividend yield
 
 
0
%